Evidence map›Paper›PMID 37311463›Full record

ArticleMolecular cell2023

Histone H3 lysine 27 crotonylation mediates gene transcriptional repression in chromatin.

Nan Liu, Tsuyoshi Konuma, Rajal Sharma, Deyu Wang, Nan Zhao, Lingling Cao, Ying Ju, Di Liu, Shuai Wang, Almudena Bosch and 21 more

Open access · greenAbstract read
In one paragraph

Article in Molecular cell, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
9.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 8 institutions in 3 countries.

Nan LiuBethune Institute of Epigenetic Medicine, First Hospital of Jilin University, Changchun 130061, China; International Center of Future Science, Jilin University, Changchun 130012, China. Electronic address: nanliu@mail.jlu.edu.cn.
Tsuyoshi KonumaDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Graduate School of Medical Life Science, Yokohama City University, Yokohama 230-0045, Japan; School of Science, Yokohama City University, Yokohama 230-0045, Japan.
Rajal SharmaDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Deyu WangBethune Institute of Epigenetic Medicine, First Hospital of Jilin University, Changchun 130061, China.
Nan ZhaoBethune Institute of Epigenetic Medicine, First Hospital of Jilin University, Changchun 130061, China.
Lingling CaoBethune Institute of Epigenetic Medicine, First Hospital of Jilin University, Changchun 130061, China.
Ying JuBethune Institute of Epigenetic Medicine, First Hospital of Jilin University, Changchun 130061, China.
Di LiuBethune Institute of Epigenetic Medicine, First Hospital of Jilin University, Changchun 130061, China.
Shuai WangBethune Institute of Epigenetic Medicine, First Hospital of Jilin University, Changchun 130061, China.
Almudena BoschDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Yifei SunDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Siwei ZhangDepartment of Pharmacology, College of Basic Medical Sciences, Jilin University, Changchun 130000, China.
Donglei JiBethune Institute of Epigenetic Medicine, First Hospital of Jilin University, Changchun 130061, China.
Satoru NagatoishiInstitute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
Noa SuzukiSchool of Science, Yokohama City University, Yokohama 230-0045, Japan.
Masaki KikuchiRIKEN Center for Biosystems Dynamics Research, Yokohama 230-0045, Japan.
Masatoshi WakamoriRIKEN Center for Biosystems Dynamics Research, Yokohama 230-0045, Japan.
Chengcheng ZhaoBethune Institute of Epigenetic Medicine, First Hospital of Jilin University, Changchun 130061, China.
Chunyan RenDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Thomas Jiachi ZhouDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Yaoyao XuBethune Institute of Epigenetic Medicine, First Hospital of Jilin University, Changchun 130061, China.
Jamel MeslamaniDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Shibo FuBethune Institute of Epigenetic Medicine, First Hospital of Jilin University, Changchun 130061, China; International Center of Future Science, Jilin University, Changchun 130012, China.
Takashi UmeharaRIKEN Center for Biosystems Dynamics Research, Yokohama 230-0045, Japan.
Kouhei TsumotoInstitute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan; Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, Tokyo 113-8656, Japan.
Satoko AkashiGraduate School of Medical Life Science, Yokohama City University, Yokohama 230-0045, Japan; School of Science, Yokohama City University, Yokohama 230-0045, Japan.
Lei ZengBethune Institute of Epigenetic Medicine, First Hospital of Jilin University, Changchun 130061, China; International Center of Future Science, Jilin University, Changchun 130012, China.
Robert G RoederLaboratory of Biochemistry and Molecular Biology, the Rockefeller University, New Nork, NY 10065, USA.
Martin J WalshDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Qiang ZhangBethune Institute of Epigenetic Medicine, First Hospital of Jilin University, Changchun 130061, China; International Center of Future Science, Jilin University, Changchun 130012, China. Electronic address: qiangzhang@jlu.edu.cn.
Ming-Ming ZhouDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Electronic address: ming-ming.zhou@mssm.edu.
Jilin University · CNIcahn School of Medicine at Mount Sinai · USRIKEN Center for Biosystems Dynamics Research · JPYokohama City University · JPRockefeller University · USThe University of Tokyo · JPTokyo Medical University · JPYokohama City University Medical Center · JP

Funding

STRUCTURE OF PROTEIN MODULES IN CHROMATIN REMODELINGR01CA087658 · NCI · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI ZHOU, MING-MING · 2000 to 2016
$4.8M
Epigenetic Control of Human Beta Cell ProliferationR01DK116873 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ARGMANN, CARMEN, SCOTT, DONALD K. · 2018 to 2022
$3.2M
Non-coding RNAs for Epigenetic Transcriptional Silencing in Prostate CancerR01CA154809 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI WALSH, MARTIN JOHN, ZHOU, MING-MING · 2011 to 2015
$2.5M
Creating a Catalog of Cancer Clonotype Drug Sensitivities with Single-CellGenome SequencingDP2CA239145 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI GAWAD, CHARLES · 2018 to 2018
$2.3M
Underlying chromatin architecture defines functionality for CFTR expressionR01DK118946 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI WALSH, MARTIN JOHN · 2018 to 2022
$2.1M
COVID and Translational Science supercomputer (CATS)S10OD030463 · OD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KOVATCH, PATRICIA · 2021 to 2021
$2.0M
New Epigenetic Gene Silencing TechnologyR01GM119189 · NIGMS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI WALSH, MARTIN JOHN, ZHOU, MING-MING · 2016 to 2019
$1.8M
An AVANCE NEO 600 MHz NMR Spectrometer System for Structural and Chemical BiologyS10OD025132 · OD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ZHOU, MING-MING · 2019 to 2019
$535k
NCI NIH HHS DP2 CA239145NCI NIH HHS R01 CA087658NCI NIH HHS R01 CA154809NIDDK NIH HHS R01 DK118946NIGMS NIH HHS R01 GM119189NIH HHS S10 OD025132NIH HHS S10 OD030463
6 · The paper itself

Abstract

Histone lysine acylation, including acetylation and crotonylation, plays a pivotal role in gene transcription in health and diseases. However, our understanding of histone lysine acylation has been limited to gene transcriptional activation. Here, we report that histone H3 lysine 27 crotonylation (H3K27cr) directs gene transcriptional repression rather than activation. Specifically, H3K27cr in chromatin is selectively recognized by the YEATS domain of GAS41 in complex with SIN3A-HDAC1 co-repressors. Proto-oncogenic transcription factor MYC recruits GAS41/SIN3A-HDAC1 complex to repress genes in chromatin, including cell-cycle inhibitor p21. GAS41 knockout or H3K27cr-binding depletion results in p21 de-repression, cell-cycle arrest, and tumor growth inhibition in mice, explaining a causal relationship between GAS41 and MYC gene amplification and p21 downregulation in colorectal cancer. Our study suggests that H3K27 crotonylation signifies a previously unrecognized, distinct chromatin state for gene transcriptional repression in contrast to H3K27 trimethylation for transcriptional silencing and H3K27 acetylation for transcriptional activation.

Indexed as

ChromatinHistonesAcetylationAnimalsGene Expression RegulationLysineMiceTranscription FactorsChromatinHistonesLysineTranscription Factorscrystal structureGAS41gene transcriptional repressionhistone lysine crotonylationYEATS domain

Identifiers

PMID37311463
PMCPMC11138481
OpenAlexW4380321986

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.